Top IVD Companies in Saudi Arabia (2025 Rankings)
12 Jun, 2025

This Saudi Arabia In Vitro Diagnostics Market size will be US$ 1.68 billion by 2033. Meanwhile, its share in 2024 stood at US$ 1.15 billion and is poised to grow at a compound annual growth rate of 4.30% from 2025 to 2033. At the moment, Saudi Arabia is the GCC's biggest market for in-vitro diagnostics. The Saudi Arabian healthcare system relies heavily on in-vitro diagnostics since it offers precise diagnosis and prognosis, allowing for better treatment and monitoring. Despite accounting for a relatively tiny portion of overall healthcare spending, diagnostics play a vital role in medical decision-making, disease burden reduction, and cost reduction.  

The use of in-vitro diagnostics has steadily increased in Saudi Arabia. The market for in-vitro diagnostics in Saudi Arabia is mostly driven by rising incidence rates of both infectious and chronic disorders. With a present population of over 33 million, the nation is expanding at a rate of about 2% each year. The General Authority of Statistics in Saudi Arabia reports that the elderly make up 4.2% of the country's overall population and are predicted to become even more in the years to come. 

One of the highest obesity rates in the world is found in Saudi Arabia. An estimated 36% of the population is thought to be obese. Furthermore, the prevalence of hypertension was around 24% in women and 29% in men. About 19% of Saudi Arabia's adult population has diabetes, making it one of the countries with the highest rates of the disease. The expansion of in-vitro diagnostics in Saudi Arabia is also being driven by a number of other factors, such as increased healthcare spending, better healthcare infrastructure, government efforts, more awareness, etc. 

Discover key trends, growth opportunities, and major challenges shaping the Saudi Arabia In Vitro Diagnostics Industry in Renub Research’s latest in-depth market report. Download your free sample now 

List of Leading Companies in the Saudi Arabia In Vitro Diagnostics Market 

Roche Diagnostics

Establishment: 1896 

Headquarters: Switzerland  

Website: www.roche.ch/en/sites/rotkreuz/about-roche-diagnostics-international 

Clinics, labs, and physician offices can obtain diagnostic system solutions from Roche Diagnostics International Ltd (Roche Diagnostics), a division of F. Hoffmann-La Roche Ltd. The business creates, manufactures, and maintains software and equipment systems for in-vitro diagnostics and bioanalytical research. Additionally, it provides molecular diagnostic reagents, test systems, workflow solutions, and diagnostic analysis systems. Blood glucose meters and point-of-care testing equipment are among its main offerings. Hospitals, commercial diagnostic labs, medical professionals, researchers, and pharmacists are among the clients the firm serves with its goods and services. The headquarters of Roche Diagnostics are located in Rotkreuz, Switzerland. 

Danaher Corporation

Establishment: 1984 

Headquarters: United States of America  

Website: www.danaher.com 

Revenue: $23.9B in 2023 

The scientific and technology firm Danaher Corp (Danaher) works in the fields of biotechnology, life sciences, and diagnostics. Testing equipment, medical diagnostics, life science research tools, reagents and mass spectrometry, professional microscopes, genomic consumables, filtration and flow cytometry, lab automation, centrifugation, particle counting, and characterization businesses are all offered by the company. Through independent distributors throughout the Americas, Europe, the Middle East, Africa, and Asia-Pacific, Danaher provides its goods and services to pharmaceutical and biotechnology firms, healthcare providers, and research institutes. Its production plants are located in the Americas, Asia, Australia, and Europe. The US city of Washington, DC, is home to Danaher's headquarters. 

Abbott Laboratories

Establishment: 1888 

Headquarters: United States of America  

Website: www.abbott.com 

Revenue: $42.0B in 2023 

Abbott Laboratories (Abbott) is a health care and medical device corporation that develops, creates, produces, and markets goods. Products related to gastroenterology, women's health, cardiovascular and metabolic, pain and central nervous system, respiratory drugs and vaccines, biosimilars, core laboratory and transfusion medicine systems, point-of-care systems, rapid diagnostics lateral flow testing, informatics and automation solutions, nutritional products, rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products, and neuromodulation products are among its primary offerings. The business sells its goods to consumers in North America, Latin America, the Middle East, Europe, Asia-Pacific, and Africa through distributors, wholesalers, government organizations, hospitals, pharmacies, and independent merchants. The US headquarters of Abbott are located in Abbott Park, Illinois. 

Thermo Fisher Scientific Inc.

Establishment: 1956 

Headquarters: United States of America 

Website: www.thermofisher.com 

Revenue: $42.9B in 2023 

Thermo Fisher Scientific Inc. (Thermo Fisher) provides laboratory, pharmaceutical, biotechnology, and specialty diagnostic services in addition to analytical tools and life sciences solutions. Chemicals, cell culture materials, tools for analyzing proteins and cells, clinical and diagnostic tools, chromatography and mass spectrometry devices, laboratory supplies, equipment, instruments, and goods for molecular biology and nucleic acid analysis are among its offerings. Through the Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD brands, the corporation distributes its goods to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research organizations, and government agencies. It uses a direct sales force, customer care agents, online sales, and independent distributors to sell its goods. The US city of Waltham, Massachusetts, is home to Thermo Fisher's headquarters. 

Bio–Rad Laboratories, Inc.

Establishment: 1952 

Headquarters: United States of America 

Website: www.bio-rad.com 

Revenue: $2.6B in 2023 

Instruments, software, consumables, and reagents are developed, produced, and marketed by Bio-Rad Laboratories Inc. (Bio-Rad) for use in clinical diagnostics and life science research. Among its products are digital PCR, blood type and antibody detection systems, antibodies, autoimmune testing kits, and equipment for cell isolation and analysis. Among other fields, the company's products are used in immunology, gene expression analysis, cell research, bioprocess analytics, and mutation detection. It provides services to hospitals, public health and commercial laboratories, universities and research organizations, diagnostic manufacturers, and businesses in the food, chemical, pharmaceutical, and biotechnology sectors. Bio-Rad distributes its goods via distributors, agencies, brokers, resellers, and direct sales channels. Among other places, the business operates in the US, Germany, France, China, and Singapore. The US city of Hercules, California, is home to Bio-Rad's headquarters. 

Sysmex Corporation

Establishment: 1968 

Headquarters: Japan  

Website: www.sysmex.co.jp 

Revenue: $3.2B in 2023 

Medical device manufacturer Sysmex Corp (Sysmex) conducts research, develops, manufactures, and markets tools, reagents, and software applications that help with disease management, treatment, and health examinations. It provides clinical laboratories with laboratory information systems, reagents, and diagnostic equipment for testing. Haematology, hemostasis, and urinalysis analyzers are among the products that the firm sells. Medical facilities make use of its products. At its locations in Germany, France, New Zealand, Japan, and the US, it carries out research and development. In the Americas, Europe, the Middle East, Africa, and Asia Pacific, the corporation and its subsidiaries conduct business. The headquarters of Sysmex are located in Hyogo, Japan. 

Becton

Establishment: 1897 

Headquarters: United States of America 

Website: www.bd.com 

Revenue: $20.2B in 2023 

One business that makes medical technology is Becton Dickinson and Co. (BD). It produces and sells diagnostic items, medical gadgets, lab equipment, and supplies. Vascular and urological devices, surgical instruments, molecular diagnostic systems, infusion pumps, pre-fillable medication delivery systems, hemodynamic monitoring equipment, and cell analysis solutions are among the company's product offerings. Healthcare facilities, doctors, life science researchers, clinical labs, the pharmaceutical industry, and the general public are all served by BD's products. Bosnia & Herzegovina, Brazil, Canada, the United States, France, Germany, Hungary, India, Japan, Mexico, and the Dominican Republic are just a few of the nations where the corporation operates manufacturing facilities. The US city of Franklin Lakes, New Jersey, is home to BD's headquarters. 

Biomerieux

Establishment: 1963 

Headquarters: France 

Website: www.biomerieux.fr 

Revenue: $4.3B in 2023 

A division of Institut Merieux SA, bioMerieux SA (bioMerieux) creates, produces, and sells in vitro diagnostic products for use in private and medical labs. In addition to detecting microorganisms in medications, cosmetics, and agri-food items, the firm provides diagnostic solutions, including systems, reagents, and software, for the detection of infectious illnesses, cardiovascular disorders, and malignancies. It provides industrial microbiological control solutions for the food, pharmaceuticals, and cosmetic sectors; veterinary diagnostic labs; blood banks; and immunoassays, microbiology products, molecular biology tests, and other solutions for clinical applications. Additionally, bioMerieux offers systems for counting the bacterial flora, which reveal the quality of food items. The business sells its goods both directly and via a global network of distributors. The headquarters of bioMerieux are located in Marcy l'Etoile, France.